References
- Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146:6 - 7
- Gruver AL, Hudson LL, Sempowski GD. Immunosenescence of ageing. J Pathol 2007; 211:144 - 156
- Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681 - 1691
- Kasiske B, Snyder J, Gilbertson D, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905 - 913
- Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, et al. The janus face of immunosuppression—de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int 2007; 71:1271 - 1278
- Wu JJ, Orengo IF. Squamous cell carcinoma in solid-organ transplantation. Dermatol Online J 2002; 8:4
- Brewer JD, Colegio OR, Phillips PK, Roenigk RK, Jacobs MA, Van de Beek D, et al. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009; 145:1391 - 1396
- Kuklina EV, Yoon PW, Keenan NL. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999–2006. JAMA 2009; 302:2104 - 2110
- Goldstein MR, Mascitelli L, Pezzetta F. The double-edged sword of statin immunomodulation. Int J Cardiol 2009; 135:128 - 130
- Chin C, Lukito SS, Shek J, Bernstein D, Perry SB. Prevention of pediatric graft coronary artery disease: atorvastatin. Pediatr Transplant 2008; 12:442 - 446
- Mausner-Fainberg K, Luboshits G, Mor A, et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis 2008; 197:829 - 839
- Goldstein MR, Mascitelli L, Pezzetta F. Statins, regulatory T cells, and pediatric graft coronary artery disease. Pediatr Transplant 2009; 13:139 - 140
- Goldstein MR, Mascitelli L, Pezzetta F. Statins, Tregs and cancer. Atherosclerosis 2008; 196:483 - 484
- Mallat Z, Ait-Oufella H, Tedgui A. Regulatory T cell responses: Potential role in the control of atherosclerosis. Curr Opin Lipidol 2005; 16:518 - 524
- Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007; 117:1167 - 1174
- Jang TJ. Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors. Yonsei Med J 2008; 49:942 - 948
- Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383 - 1389
- Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7 - 22
- Ridker PM, Friedewald VE, Davidson MH, Willerson JT, Roberts WC. The Editor's roundtable: The JUPITER Trial—initial results and clinical implications. Am J Cardiol 2009; 103:1417 - 1425